Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.61 |
| ▸ | TK2 | O00142 | 2/20 | 0.56 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.52 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.52 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.52 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.52 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.48 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.48 |
| ▸ | TYMP | P19971 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18512878 | 1.00 | PYGM (0.61) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL18512877 | 1.00 | PYGM (0.61) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL442314 | 0.93 | PYGM (0.53) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL28299287 | 0.89 | PYGM (0.58) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL14853756 | 0.88 | PYGM (0.57) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL14930959 | 0.88 | PYGM (0.57) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL14842287 | 0.88 | PYGM (0.57) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL546996 | 0.88 | PYGM (0.57) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL14929088 | 0.88 | PYGM (0.57) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL18161337 | 0.86 | PYGM (0.55) | PYGMTK2SLC28A1SLC28A2SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2178 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304965-A1 | DOUBLE-STRANDED RNA MOLECULE AND PHARMACEUTICAL USE THEREOF | MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-10-02 | — | — | US | claimed |
| EP-4481057-A1 | SAMPLE PREPARATION METHODS USING MODIFIED BASES FOR RAPID IDENTIFICATION AND SEQUENCING | Depixus (FR) | 2024-12-25 | — | — | EP | claimed |
| US-20220145295-A1 | ENZYMATIC RNA SYNTHESIS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-05-12 | — | — | US | claimed |
| EP-3864151-A2 | ENZYMATIC RNA SYNTHESIS | President and Fellows of Harvard College (US) | 2021-08-18 | — | — | EP | claimed |
| CN-113195720-A | Enzymatic RNA synthesis | 哈佛大学的校长及成员们 | 2021-07-30 | — | — | CN | claimed |
| US-10441653-B2 | Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant | CUREVAC AG (DE) | 2019-10-15 | — | — | US | claimed |
| US-10307434-B2 | Nucleic acid prodrugs and methods of use thereof | WAVE LIFE SCIENCES LTD. (SG) | 2019-06-04 | — | — | US | claimed |
| EP-3394327-A1 | DNA-ENCODED CHEMICAL LIBRARY, USE THEREOF AND METHOD TO SYNTHESIZE THE LIBRARY | Technische Universität Dortmund (DE) | 2018-10-31 | — | — | EP | claimed |
| US-9744183-B2 | Nucleic acid prodrugs and methods of use thereof | WAVE LIFE SCIENCES LTD. (SG) | 2017-08-29 | — | — | US | claimed |
| WO-2017108741-A1 | DNA-ENCODED CHEMICAL LIBRARY, USE THEREOF AND METHOD TO SYNTHESIZE THE LIBRARY | TECHNISCHE UNIVERSITÄT DORTMUND (DE) | 2017-06-29 | — | — | WO | claimed |
| US-20150211004-A1 | RNAI-BASED THERAPIES FOR CARDIOMYOPATHIES, MUSCULAR DYSTROPHIES AND LAMINOPATHIES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-07-30 | — | — | US | claimed |
| EP-2838541-A1 | RNAI-BASED THERAPIES FOR CARDIOMYOPATHIES, MUSCULAR DYSTROPHIES AND LAMINOPATHIES | Agency For Science, Technology And Research (SG) | 2015-02-25 | — | — | EP | claimed |
| WO-2013158046-A1 | RNAI-BASED THERAPIES FOR CARDIOMYOPATHIES, MUSCULAR DYSTROPHIES AND LAMINOPATHIES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-10-24 | — | — | WO | claimed |
| EP-2640852-A1 | SIGNAL AMPLIFICATION | Speedx Pty Ltd (AU) | 2013-09-25 | — | — | EP | claimed |
| US-8394946-B2 | Multicomponent nucleic acid enzymes and methods for their use | SPEEDX PTY LTD (AU) | 2013-03-12 | — | — | US | claimed |
| WO-2012065231-A1 | SIGNAL AMPLIFICATION | SPEEDX PTY LTD (AU) | 2012-05-24 | — | — | WO | claimed |
| EP-1948822-A1 | MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE | JOHNSON & JOHNSON RESEARCH PTY LIMITED (AU) | 2008-07-30 | — | — | EP | claimed |
| US-20070231810-A1 | Multicomponent nucleic acid enzymes and methods for their use | SPEEDX PTY LTD (AU) | 2007-10-04 | — | — | US | claimed |
| WO-2007041774-A1 | MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE | JOHNSON & JOHNSON RESEARCH PTY LIMITED (AU) | 2007-04-19 | — | — | WO | claimed |
| US-20030007961-A1 | Orthomolecular vitamin E derivatives | WILBURN MICHAEL D (US) | 2003-01-09 | — | — | US | claimed |